PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.930
+0.070 (3.76%)
At close: May 12, 2025, 4:00 PM
1.950
+0.020 (1.04%)
After-hours: May 12, 2025, 4:57 PM EDT
PainReform Market Cap
PainReform has a market cap or net worth of $3.29 million as of May 12, 2025. Its market cap has increased by 55.33% in one year.
Market Cap
3.29M
Enterprise Value
-922.97K
1-Year Change
55.33%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on September 1, 2020, PainReform's market cap has decreased from $69.97M to $3.29M, a decrease of -95.29%. That is a compound annual growth rate of -47.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.17M | 8.12% |
| Dec 31, 2024 | 2.94M | -31.51% |
| Dec 29, 2023 | 4.29M | -2.35% |
| Dec 30, 2022 | 4.39M | -68.52% |
| Dec 31, 2021 | 13.94M | -65.00% |
| Dec 31, 2020 | 39.83M | -43.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |